Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism

Mov Disord. 2003 Oct;18(10):1190-2. doi: 10.1002/mds.10554.

Abstract

We conducted structured interviews of patients with Parkinson's disease (PD) and other parkinsonian disorders and their caregivers after augmentation of vocal folds with collagen injections. A total of 12 patients (mean age, 73.7 +/- 8.6 years) completed the questionnaire after an average of 3.0 +/- 1.7 collagen injections, with an average of 13.8 +/- 7.4 weeks between each injection. In addition to improvement in all six voice quality questions, there was significant improvement (P < 0.05) in the Glascow Benefit Inventory (GBI) score. The injection procedure was tolerated well by patients with an average duration of benefit lasting 7.8 +/- 8.5 weeks. Augmentation of vocal folds with collagen provides temporary improvement in voice in patients with parkinsonian hypophonia.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Collagen / therapeutic use*
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Parkinsonian Disorders / complications*
  • Parkinsonian Disorders / physiopathology
  • Patient Satisfaction
  • Surveys and Questionnaires
  • Time Factors
  • Treatment Outcome
  • Vocal Cords / drug effects*
  • Voice Disorders / drug therapy*
  • Voice Disorders / etiology*
  • Voice Disorders / physiopathology
  • Voice Quality

Substances

  • Collagen